Cronos Group (CRON) Q3 2026 Earnings Call Transcript

Image source: The Motley Fool.

DATE

Thursday, Nov. 5, 2026

CALL PARTICIPANTS

• Chairman, President, and Chief Executive Officer – Mike Gorenstein
• Chief Financial Officer – Anna Shlimak
• Senior Director, Investor Relations and Corporate Development – Harrison Aaron

TAKEAWAYS

• Net Revenue — $63.5 million, growing 75% year over year driven by higher flower sales in Israel, Germany, and Canada.
• Gross Profit — $32.3 million, a 76% increase from the prior year reflecting higher average sales prices and improved overhead cost absorption.
• Adjusted EBITDA — $17.1 million, an improvement of $11.4 million year over year due to higher gross profit despite increased operating expenses.
• Israel Net Revenue — Growing 33% year over year (19% on a constant currency basis), marking the 11th consecutive record quarter for the region.
• Canadian Retail Sales Growth — 41% year over year for Spinach branded products, significantly exceeding the industry-wide sales growth of 1%.
• International Revenue (Ex-Israel) — $13.2 million, up from $1.9 million in the prior year primarily led by demand in the German market.
• Cash and Investments — $841 million, including cash, short-term investments, and interest-bearing deposits as of the end of the quarter.
• Vape Market Share — 11.4% in Canada, maintaining the number one position for the third consecutive quarter.
• Vape Cartridge Subcategory Share — 12.1% in Canada, representing the fourth consecutive quarter in the top position.
• Edibles Market Share — 21.8% in Canada, with the SOURZ brand holding the number one position for nine consecutive quarters.
• Gummies Subcategory Share — 23.6% in Canada, supported by four of the top seven edible SKUs nationwide.
• Flower Market Share — 6.1% in Canada, where the Spinach brand ranked number three with two SKUs in the top seven nationwide.
• Pre-roll Market Share — 3.3% in Canada, climbing to the number five rank as the brand assortment renovation gains traction.
• Operating Expenses — $23.3 million, representing 37% of net revenue compared to 52% in the third quarter of 2025.
• Capital Expenditures — $9.9 million, focused on capacity expansion and facility investments.
• Share Repurchases — $9.4 million, representing the buyback of 3.2 million shares during the third quarter.
• Netherlands Acquisition Valuation — Less than 3 times trailing Adjusted EBITDA, for the purchase of CanAdelaar completed in Oct. 2026.
• Operating Cash Flow — $34 million, which included a $12 million benefit from working capital inflows.
• Infused Pre-roll Share — 3.8% in Canada, ranking the Spinach brand sixth in the category.
• Traditional Pre-roll Share — 3% in Canada, where the brand also ranked sixth.
• All-in-one Vape Share — 10.2% in Canada, driven by the PUFFERZ product innovation.

Need a quote from a Motley Fool analyst? Email [email protected]

RISKS

• Gorenstein stated, “like every new adult-use market, we still expect price compression now that suppliers have had a chance to ramp up and meet demand,” regarding the entry into the Netherlands market.
• Gorenstein noted that the company has observed price compression in Germany as the market matures and supply approaches equilibrium.
• Management stated that strong product demand continues to result in tight flower supply, which acts as a constraint on potential sales volume.

SUMMARY

Cronos Group Inc. (CRON -3.09%) reported record financial performance across its primary operating regions, supported by its borderless product strategy and international expansion into the European adult-use market. Management noted that the company is leveraging its Canadian product success, particularly in vapes and edibles, to establish a presence in newly legalizing or maturing markets like Germany and the Netherlands. The company maintained its focus on operational efficiency, resulting in a reduction of operating expenses as a percentage of revenue even as it invests in growth initiatives and product innovation. Furthermore, the company continues to utilize its balance sheet to return capital through share repurchases while pursuing strategic acquisitions.

• Management highlighted the October acquisition of CanAdelaar, the largest adult-use operator in the Netherlands, as a platform for establishing branded products across Europe.
• CEO Gorenstein noted that the Dutch market experiment currently covers less than 10% of the population, providing asymmetric value if the pilot program expands.
• The company reported that demand for flower products remains high, resulting in tight supply even with the additional capacity coming online from the late 2025 GrowCo expansion.
• Management stated that the Dutch cannabis framework avoids excise tax disadvantages often seen in North American legal markets.
• CFO Shlimak indicated that gross margins may fluctuate from quarter to quarter due to product mix and seasonal purchasing patterns by Canadian provincial boards.
• CEO Gorenstein stated, “integration, including IP transfer, is well underway” following the acquisition of the Dutch operations.

INDUSTRY GLOSSARY

• Adjusted EBITDA: A non-GAAP financial measure that excludes non-cash items and expenses not reflecting ongoing business performance to evaluate operational results.
• Constant Currency: A reporting method that removes the effects of foreign exchange rate fluctuations to compare financial results between periods.
• Excise Tax: A legislated tax on specific goods or services, such as cannabis, often applied at the point of manufacture or sale.
• HiFyre: A retail analytics platform that provides market share and sales data for the cannabis industry.
• Live Resin: A cannabis concentrate produced from fresh-frozen plant material to preserve the flavor and aroma profile of the living plant.
• Non-GAAP: Financial measures that do not follow Standardized Accounting Principles, used by management to provide supplemental performance information.
• SKU: Stock Keeping Unit, a unique identifier for a specific product or service used in inventory management.
• Wietexperiment: The Dutch Controlled Cannabis Supply Chain Experiment, a pilot program for the legal production and sale of adult-use cannabis in the Netherlands.

Full Conference Call Transcript

Operator: Good morning. My name is Stephanie, and I will be your conference operator today. I would like to welcome everyone to Cronos’ 2026 third quarter conference call. Today’s call is being recorded. At this time, I would like to turn the call over to Harrison Aaron, Senior Director, Investor Relations and Corporate Development. Please go ahead.

Harrison Aaron: Thank you, Stephanie, and thank you for joining us today to review Cronos’ 2026 Q3 financial and business performance. Today, I am joined by our Chairman, President, and CEO, Mike Gorenstein, and our CFO, Anna Shlimak

Source: www.fool.com — article syndicated from the publisher’s feed; all rights remain with the original publisher.